-
AI, Machine Learning & Computational Biology6 months agoEli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy
On this week’s episode of “The Readout LOUD”: Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You’ve been warned....
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. The FDA granted accelerated approval...
-
AI, Machine Learning & Computational Biology6 months agoHealth influencers talk social media and mental health
A jury in Los Angeles has found social media giants Google and Meta liable for the mental health struggles of a 20-year-old woman, awarding her $3...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: A surprise opening for health care reforms
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...
-
AI, Machine Learning & Computational Biology6 months agoWhite House misses deadline to nominate new CDC director
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. So you know how Theresa said yesterday that...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: Data show people racing to chatbots for health advice
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your...
-
AI, Machine Learning & Computational Biology6 months ago
Pulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses
Pulmatrix may have been discarded by Cullgen, but the inhaled therapy biotech’s Nasdaq listing has caught the attention of another company.Read More
-
AI, Machine Learning & Computational Biology6 months ago
OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline
Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and China, bringing the company’s total fundraising...
-
AI, Machine Learning & Computational Biology6 months ago
Wave crashes after obesity trial tracks 1% dip in body weight over 6 months
Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down more...
-
AI, Machine Learning & Computational Biology6 months agoSTAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
The Food and Drug Administration on Wednesday approved a new medicine from Denali Therapeutics for a condition called Hunter syndrome, a notable decision by the agency...
Carbon Dots Emerge as a Powerful Weapon Against Superbugs and Biofilms
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
Azithromycin Resistance in Gonorrhea Shifts Genetic Ground, Challenging Molecular Surveillance
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
